Docetaxel
Product Images NDC 16729-231

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Docetaxel (NDC 16729-231). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Accord Healthcare Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Docetaxel Injection 160 mg Per 8 mL Carton

Docetaxel Injection 160 mg Per 8 mL Carton
This is a drug called Docetaxel in its injection formulation. The concentration of Docetaxel in the injection is 20 mg/ml and comes in a sealed 8 mL vial, which could be added to infusion solution for intravenous injection. It is important to ensure the dosage and administration instructions before use. The drug should be kept out of children's reach, and from direct high heat sources.*
FDA Label Image

Docetaxel Injection 20 mg Per mL Carton

Docetaxel Injection 20 mg Per mL Carton
This is a description of Docetaxel Injection USP, a medication used for intravenous infusion only. The medication is available in a 20 mg/mL concentration and comes in a 1 mL multiple dose vial. The vial contains only 1 mL of the medication. The text also includes instructions on how to prepare the medication for infusion.*
FDA Label Image

Docetaxel Injection 80 mg Per 4 mL Carton

Docetaxel Injection 80 mg Per 4 mL Carton
Docetaxel Injection USP is a medication used for the treatment of different types of cancer. It comes in a vial with 80mg/4mL strength and contains 20mg/mL concentration. The medication is ready to add to the infusion solution, and further dosage information is available on the package. The given text contains some spacing and inaccuracies, but the general purpose and description of the medication are understandable.*
FDA Label Image

Docetaxel Injection (Docetaxel Injection Image01)

FDA Label Image

Docetaxel Injection (Docetaxel Injection Image02)

FDA Label Image

Docetaxel Injection (Docetaxel Injection Image03)

FDA Label Image

Docetaxel (Docetaxel Injection Image04)

Docetaxel (Docetaxel Injection Image04)
This appears to be a partial table showing the cumulative probability and survival time in months for a certain event. There are also references to Logerank p values. However, without full context, it is difficult to provide a more detailed description of the data presented.*
FDA Label Image

Docetaxel (Docetaxel Injection Image05)

Docetaxel (Docetaxel Injection Image05)
This appears to be a chart showing a cumulative probability for overall survival based on survival time in months. The x-axis represents survival time in months, while the y-axis shows the cumulative probability from 0 to 1. The chart also includes a log-rank p-value of 0.13 and some additional numerical values, but it is not clear what they represent without further context.*
FDA Label Image

Docetaxel Injection (Docetaxel Injection Image06)

Docetaxel Injection (Docetaxel Injection Image06)
The text appears to be a graph with headings for "SURVIVAL PROBABILITY" and "SURVIVAL TIME (MONTHS)". The X-axis shows the survival time in months with values of 9, 12, 15, 18, and 21. The Y-axis shows the survival probability with a value of 0 at the bottom and 1 at the top. However, without a visual representation of the graph, it is not possible to provide a more specific description.*
FDA Label Image

Docetaxel (Docetaxel Injection Image07)

Docetaxel (Docetaxel Injection Image07)
This appears to be a chart or graph with no additional information provided. Therefore, a useful description cannot be generated.*
FDA Label Image

Docetaxel (Docetaxel Injection Image08)

Docetaxel (Docetaxel Injection Image08)
This is a table or chart displaying survival probability in percentage over time (in months). The time intervals range from 12 to 24 months. No further information is available.*
FDA Label Image

Docetaxel Injection (Docetaxel Injection Image09)

FDA Label Image

Docetaxel Injection (Docetaxel Injection Image10)

Docetaxel Injection (Docetaxel Injection Image10)
This is a partial table showing survival probability in percentage for a certain survival time in months, ranging from 10 months to 48 months. The table is missing some headings and therefore, the context of the data is not clear.*
FDA Label Image

Docetaxel Injection (Docetaxel Injection Image11)

Docetaxel Injection (Docetaxel Injection Image11)
This text seems to be a table showing survival probability of patients at different time periods (6, 12, 18, 24, 30, 36, 42, 43, 54, 60, 66, and 72 months) categorized by two groups, TPF and PF, with the corresponding number of patients at risk and the number who survived. However, the characters in the table are not readable or recognizable, therefore the description may not be entirely accurate.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.